Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised HiFiBiO Therapeutics on the deal. FibroGen, Inc. (Nasdaq: FGEN) and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, Inc., the organism company, closed a collaboration and license agreement with Biogen (Nasdaq: BIIB) to...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised The Valens Company Inc. on the deal. The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of cannabis products, announced a...
You must be a Standard 1 Year member to access this content.
